Am J Transplant, Volume 19, Suppl 3 Archives - Page 206 of 214 - ATC Abstracts

2019 American Transplant Congress
The Impact of KDPI on Post Transplant Kidney Function: Intercept versus Slope. A Single Center Study
M. Molinari¹, D. Jorgensen², R. Mehta³, P. Sood³, A. Ganoza², C. Puttarajappa³, R. Lopez², M. Wijkstrom², A. Tevar², S. Hariharan³
¹University of Pittsburgh Medical Centre, Pittsburgh, PA, ²Surgery, University of Pittsburgh Medical Centre, Pittsburgh, PA, ³Medicine, University of Pittsburgh Medical Centre, Pittsburgh, PA
*Purpose: We evaluated the impact of Kidney Donor Profile Index (KDPI) on post-transplant renal function and graft survival.*Methods: Between January-2013 and December- 2017, a total…
2019 American Transplant Congress
Long-Term Efficacy and Safety of Everolimus Based Immunosuppression on De Novo Kidney Transplantation with 10 Years Follow-Up
Y. Watarai¹, S. Narumi¹, T. Tomosugi¹, K. Futamura², M. Okada¹, M. Tsujita², T. Hiramitsu¹, T. Kobayashi³, N. Goto²
¹Transplant Surgery, Nagoya Daini Red Cross Hospital, Nagoya, Japan, ²Transplant Nephrology, Nagoya Daini Red Cross Hospital, Nagoya, Japan, ³Kidney Transplantation, Aichi Medical University, Nagoya, Japan
*Purpose: Long-term efficacy and safety of everolimus (EVR) based immunosuppression for de novo kidney transplant recipient who were involved in A1202 study from our institute…
2019 American Transplant Congress
Clinical Implications of Belatacept Conversion in a High-Risk, Urban Renal Transplant Population
B. Valdepenas, J. Benken, E. Benedetti, Z. Hajjiri, A. Lichvar
University of Illinois at Chicago, Chicago, IL
*Purpose: Conversion to belatacept as maintenance immunosuppression has gained traction to prevent calcineurin inhibitor (CNI) induced toxicities in renal transplant (RTx) recipients. However, limited knowledge…
2019 American Transplant Congress
Calcineurin Inhibitor Holiday for Management of Post Transplant Acute Kidney Injury
S. Sriperumbuduri, D. Lazarus, T. Fairhead, S. Hoar, J. Karpinski, G. Knoll
Nephrology, The Ottawa hospital, Ottawa, ON, Canada
*Purpose: Calcineurin inhibitors (CNI), despite dominating the armamentarium of post transplant medications, are associated with long term nephrotoxicity and also delayed recovery of renal function…
2019 American Transplant Congress
Long-Term Outcomes of Early Conversion to Sirolimus-Based Immunosuppression in Children with Living Donor Kidney Transplants
B. Stotter¹, S. Lui¹, E. Weller², L. Ganapathi¹, M. Ferguson¹, A. Traum¹, M. Somers¹, N. Rodig¹
¹Pediatrics, Boston Children's Hospital, Boston, MA, ²Biostatistics and Research Design Center, Boston Children's Hospital, Boston, MA
*Purpose: Following kidney transplantation (KTx), calcineurin inhibitor (CNI)-based maintenance immunosuppression (IS) can be associated with nephrotoxicity and other complications including viral infections and malignancy. Mammalian…
2019 American Transplant Congress
Outcomes of En Bloc Simultaneous Liver-Kidney Transplantation Compared to the Traditional Technique
A. R. Cortez, T. C. Lee, A. Kassam, M. C. Morris, L. K. Winer, L. Sage Silski, M. C. Cuffy, T. S. Diwan, R. C. Quillin, S. A. Shah
University of Cincinnati, Cincinnati, OH
*Purpose: Simultaneous liver-kidney transplantation (SLKT) is indicated for patients with end-stage liver disease (ESLD) and concurrent renal insufficiency. En bloc SLKT has been reported as…
2019 American Transplant Congress
Liver Transplant Centers Select Different Characteristics for Recipients and Deceased Donors: Implications for Patients When Choosing a Center
C. R. Schaffhausen¹, M. J. Bruin², S. Chu², D. Schladt¹, S. Chinnakotla³, J. R. Lake⁴, W. Kim⁵, S. W. Biggins⁶, J. J. Snyder⁷, B. L. Kasiske⁷, A. K. Israni¹
¹Hennepin Healthcare Research Institute, Minneapolis, MN, ²College of Design, University of Minnesota, Minneapolis, MN, ³Department of Surgery, University of Minnesota, Minneapolis, MN, ⁴Division of Gastroenterology, Hepatology, and Nutrition, University of Minnesota, Minneapolis, MN, ⁵Division of Gastroenterology and Hepatology, Stanford University, Stanford, CA, ⁶Division of Gastroenterology, University of Washington, Seattle, WA, ⁷Scientific Registry of Transplant Recipients, Minneapolis, MN
*Purpose: When patients can choose the liver transplant center at which to establish care, a prior knowledge of center acceptance practices (of candidates and donors)…
2019 American Transplant Congress
De-Novo Letermovir Resistant Mutations in Cytomegalovirus-Infected Tissues of Solid Organs Transplant Recipients
S. HAN, H. Cho, S. Min, Y. Hong
Internal Medicine, Yonsei University Health System, Yonsei University College of Medicine, Seoul, Korea, Republic of
*Purpose: Letermovir, cytomegalovirus (CMV) DNA-terminase complex (UL51, UL56, and UL89) inhibitor, revealed the efficient prophylactic effect against CMV infection including disease and DNAemia with low-grade…
2019 American Transplant Congress
Candida auris after Liver Transplant
N. M. Theodoropoulos, R. Ellison, J. S. Daly, A. Bozorgzadeh, D. A. Mack, L. Gibson, S. M. Levitz
University of Massachusetts Medical School, Worcester, MA
*Purpose: C. auris is a difficult to eradicate yeast that has caused outbreaks in hospitals in recent years. We report a cluster of liver transplant…
2019 American Transplant Congress
Need For Protocol Driven Mmr/vzv Serologic Screening
A. Agarwal¹, L. Brumble¹, H. Wadei², C. Libertin¹
¹Department of Medicine, Division of Infectious Diseases, Mayo Clinic, Jacksonville, FL, ²Department of Transplant, Mayo Clinic, Jacksonville, FL
*Purpose: The current American Society of Transplantation-ID guidelines recommend the MMR and VZV serologic screening pre transplantation for of all persons born after 1956. MMR…